Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India
· Delayed Price · Currency is INR 912.65
+22.30 (2.50%)
Jul 1, 2025, 3:29 PM IST
Aarti Pharmalabs Revenue
In the fiscal year ending March 31, 2025, Aarti Pharmalabs had annual revenue of 21.15B INR with 14.17% growth. Aarti Pharmalabs had revenue of 5.64B in the quarter ending March 31, 2025, with 11.47% growth.
Revenue
21.15B
Revenue Growth
+14.17%
P/S Ratio
3.81
Revenue / Employee
10.10M
Employees
2,095
Market Cap
80.69B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Mankind Pharma | 122.07B |
| Aurobindo Pharma | 317.24B |
| Fortis Healthcare | 77.83B |